| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.0005 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.2 |